Article
Munich - Dermatologists can objectively assess a patient's response to botulinum toxin-A treatment by using a digital camera and appropriate software, according to research recently published by Mark Heckmann, M.D.
Derm In The News: September 29-October 5
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
GPP Therapies: Comparing Efficacy and Safety of Secukinumab and Ustekinumab
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Significant Proportion of Patients With AD Maintain Stable EASI With Tralokinumab Treatment
9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep